“Treatment of Relapsed Refractory CLL With Venetoclax-Rituximab During the COVID-19 Pandemic: A Daily-Life Experience in Southern Italy”. Mediterranean Journal of Hematology and Infectious Diseases 13, no. 1 (June 28, 2021): e2021042. Accessed May 27, 2026. https://www.mjhid.org/mjhid/article/view/4613.